☰

Julie M. Madden, Ph.D.

Affiliations: 
2014 Cancer Biology Wayne State University, Detroit, MI, United States 
Area:
Oncology, Cell Biology
Google:
"Julie Madden"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Raymond R. Mattingly grad student 2014 Wayne State
 (Combating resistance to epidermal growth factor receptor inhibitors in triple negative breast cancer.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Purrington K, Dyson G, Craig D, et al. (2019) Abstract 4175: Spectrum of heritable mutations in 43 known and candidate breast cancer susceptibility genes in African American women with breast cancer Epidemiology
Colacino JA, Azizi E, Brooks MD, et al. (2018) Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. Stem Cell Reports
Madden JM, Mueller KL, Bollig-Fischer A, et al. (2014) Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer. Breast Cancer Research and Treatment. 147: 283-93
Madden J, Mueller K, Bollig-Fischer A, et al. (2014) EIF4B as a Novel Target in EGFR Expressing Triple Negative Breast Cancer Annals of Oncology. 25: i21
Madden J, Mueller K, Bollig-Fischer A, et al. (2013) Abstract 1026: Combating resistance to EGFR inhibitors: eIF4B as a novel target. Cancer Research. 73: 1026-1026
Mueller KL, Powell K, Madden JM, et al. (2012) EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK. Translational Oncology. 5: 327-34
Mueller KL, Madden JM, Zoratti GL, et al. (2012) Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. Breast Cancer Research : Bcr. 14: R104
Madden J, Mueller K, Bollig-Fischer A, et al. (2012) Abstract 1068: Inhibition of the phosphorylation of eIF4 molecules sensitizes EGFR expressing breast cancers to EGFR inhibitors Cancer Research. 72: 1068-1068
See more...